Related Experiment Videos
Side effects of interferon-alpha therapy
Stefan Sleijfer1, Marjolein Bannink, Arthur R Van Gool
1Department of Medical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, P.O. Box 5201, 3008, Rotterdam, AE, The Netherlands. s.sleijfer@erasmusmc.nl
Pharmacy World & Science : PWS
|December 13, 2005
Summary
Interferon-alpha (IFN-alpha) treatment can cause numerous side effects impacting efficacy. Understanding IFN-alpha toxicity mechanisms and management strategies is crucial for optimizing patient outcomes.
Area of Science:
- Pharmacology
- Toxicology
- Immunology
Background:
- Interferon-alpha (IFN-alpha) is a widely used therapeutic agent.
- Its application is associated with a broad spectrum of adverse events.
- These side effects can compromise treatment effectiveness and patient well-being.
Purpose of the Study:
- To review the toxicity profile of IFN-alpha.
- To explore the pathophysiology of IFN-alpha-induced side effects.
- To outline strategies for managing these adverse events.
Main Methods:
- Comprehensive literature review.
- Analysis of cross-referenced articles and books.
Main Results:
- IFN-alpha adverse effects are reported across multiple organ systems.
- Common toxicities include flu-like symptoms, hematological changes, elevated transaminases, nausea, fatigue, and psychiatric issues.
- Many side effects are dose-dependent, and management often requires dose adjustment or treatment discontinuation.
Conclusions:
- Further research is needed to elucidate the mechanisms of both therapeutic and adverse effects of IFN-alpha.
- Improved understanding may enable better patient selection for IFN-alpha therapy.
- This could lead to maximizing therapeutic benefits while minimizing severe toxicities.